Vacv Biotherapeutics (UK) Limited LONDON


Vacv Biotherapeutics (UK) Limited is a private limited company located at 120 Aldersgate Street, London EC1A 4JQ. Its total net worth is valued to be around 0 pounds, and the fixed assets that belong to the company total up to 0 pounds. Incorporated on 2019-10-18, this 4-year-old company is run by 3 directors.
Director Glyn E., appointed on 22 April 2022. Director Nicholas L., appointed on 18 October 2019. Director Yaohe W., appointed on 18 October 2019.
The company is officially categorised as "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110). According to official database there was a change of name on 2022-05-11 and their previous name was Vacv Biotherapeutics Limited.
The latest confirmation statement was sent on 2023-10-17 and the due date for the subsequent filing is 2024-10-31. Likewise, the statutory accounts were filed on 31 December 2022 and the next filing should be sent on 30 September 2024.

Vacv Biotherapeutics (UK) Limited Address / Contact

Office Address 120 Aldersgate Street
Town London
Post code EC1A 4JQ
Country of origin United Kingdom

Company Information / Profile

Registration Number 12269783
Date of Incorporation Fri, 18th Oct 2019
Industry Research and experimental development on biotechnology
End of financial Year 31st December
Company age 5 years old
Account next due date Mon, 30th Sep 2024 (155 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Thu, 31st Oct 2024 (2024-10-31)
Last confirmation statement dated Tue, 17th Oct 2023

Company staff

Glyn E.

Position: Director

Appointed: 22 April 2022

Nicholas L.

Position: Director

Appointed: 18 October 2019

Yaohe W.

Position: Director

Appointed: 18 October 2019

People with significant control

The list of PSCs that own or control the company consists of 1 name. As BizStats researched, there is Yaohe W. This PSC has 75,01-100% voting rights and has 75,01-100% shares.

Yaohe W.

Notified on 18 October 2019
Nature of control: 75,01-100% shares
75,01-100% voting rights

Company previous names

Vacv Biotherapeutics May 11, 2022

Annual reports financial information

Profit & Loss
Accounts Information Date 2020-10-312021-10-312022-12-31
Balance Sheet
Cash Bank On Hand  330 218
Current Assets11420 924
Debtors 190 706
Net Assets Liabilities11 
Other Debtors 190 706
Property Plant Equipment  14 850
Other
Accumulated Depreciation Impairment Property Plant Equipment  828
Additions Other Than Through Business Combinations Property Plant Equipment  15 678
Amounts Owed To Group Undertakings  728 868
Average Number Employees During Period 38
Creditors  1 166 271
Increase From Depreciation Charge For Year Property Plant Equipment  828
Net Current Assets Liabilities11-745 347
Other Creditors  56 839
Other Taxation Social Security Payable  16 870
Property Plant Equipment Gross Cost  15 678
Total Assets Less Current Liabilities11-730 497
Trade Creditors Trade Payables  363 694
Called Up Share Capital Not Paid Not Expressed As Current Asset11 
Number Shares Allotted 1 
Par Value Share 1 

Company filings

Filing category
Accounts Address Capital Change of name Confirmation statement Incorporation Officers Resolution
Confirmation statement with updates 2023-10-17
filed on: 28th, October 2023
Free Download (3 pages)

Company search